Roche Diagnostics cobas™ Liat SARS-CoV-2, Influenza A/B and RSV Control Kit

Description

The cobas™ liat SARS-CoV-2, Influenza A/B and RSV control kit for use with the cobas liat SARS-CoV-2, Influenza A/B and RSV assay. Control kit includes three positive and three negative controls.

The cobas™ liat SARS-CoV-2, Influenza A/B and RSV control kit for use with the cobas liat SARS-CoV-2, Influenza A/B and RSV assay. Control kit includes three positive and three negative controls.

Specifications

• Content And Storage: 20 Tests/Kit; Store at 2°C to 8°C
• Control Sets: integrated sample processing control, positive and negative controls
• CPT Code: 87637
• CE Marker: Yes
• Clia Complexity: Waived (EUA)
• Detectable Analytes: SARS-CoV-2, Influenza A and B, Rubella Virus Antibodies
• Detection Method: Nucleic Acid RT-PCR
• DoA Calibrators: No
• Format: Kit
• Sample Type: Nasaopharyngeal or anterior nasal
• Sensitivity: Influenza A, B, RSV = 100% positive agreement; SARS-CoV-2=96.7% positive agreement
• Type: Test
• Disposable: Single-use
• For Use With (Application): Detection of SARS-CoV-2, Influenza A/B, and RSV
• For Use With (Equipment): Used with the cobas™ liat analyzer
• Product Line: cobas™
• Quantity: 1
• Specificity: SARS-CoV-2=96.7% negative agreement; Influenza A = 98.1% negative agreement; Influenza B = 97.7% negative agreement; RSV = 97.2% negative agreement
• Test Time: 20 min.
• Analysis Time: 20 min.
• Dimensions (L x W x H): 10.6 x 6.5 x 5.4 in.
• Weight (English): 2.4 lb.
• Form: Ready-to-Use (RTU)